卒中教师与研究员对缺血性卒中溶栓及取栓决策的一致性
本研究评估血管神经科研究员与教师在急性缺血性卒中静脉溶栓和动脉内取栓决策上的一致性。60例患者由至少2名血管神经科医生同时评估,结果显示溶栓一致性κ=0.75,取栓κ=0.63,研究员与教师间无差异。快速改善或轻微缺损及CT灌注解读是分歧来源。
要点
- 静脉溶栓决策一致性较高(κ=0.75),取栓一致性中等(κ=0.63)
- 研究员与教师间决策一致性无差异
- 快速改善或轻微缺损及CT灌注解读是主要分歧点
核心结论
- 血管神经科研究员与教师在静脉溶栓和动脉内取栓治疗决策上具有实质性一致性。
研究设计与样本
- 60例急性缺血性卒中患者由至少2名血管神经科医生同时评估,采用κ和组内相关系数分析一致性。
主要发现
- 静脉溶栓一致性κ=0.75(95%CI 0.57-0.92),动脉内取栓一致性κ=0.63(95%CI 0.30-0.96)。
- 研究员-研究员与研究员-教师间一致性无差异。
- NIHSS的组内相关系数为0.94(95%CI 0.90-0.97),ASPECTS的κ=0.53(95%CI 0.20-0.78)。
- 快速改善或轻微缺损导致溶栓和取栓决策分歧,CT灌注解读导致取栓决策分歧。
临床怎么用
- 临床中应关注卒中模拟病的识别、轻微卒中的治疗共识以及影像使用与解读的标准化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The aim of this study is to determine agreement among vascular neurology fellows and faculty in treating patients with acute ischemic stroke with intravenous tissue-type plasminogen activator and intra-arterial thrombectomy (IAT). METHODS: Patients were evaluated simultaneously by at least 2 vascular neurology. Agreement was determined using kappa (κ) and intraclass correlation coefficients. RESULTS: In 60 patients, agreement was substantial for tissue-type plasminogen activator (κ=0.75 [95% confidence interval, 0.57-0.92]) and IAT (κ=0.63 [95% confidence interval, 0.30-0.96]), with no difference between fellow-fellow versus fellow-faculty. Intraclass correlation coefficient for National Institutes of Health Stroke Scale was 0.94 (95% confidence interval, 0.90-0.97) and κ for Alberta Stroke Program Early CT Score was 0.53 (95% confidence interval, 0.20-0.78). Rapidly improving or mild deficits caused disagreement for both tissue-type plasminogen activator and IAT, whereas interpretation of computed tomographic perfusion led to disagreement for IAT. CONCLUSIONS: We found substantial agreement between vascular neurology fellows and faculty in treating with tissue-type plasminogen activator or IAT. Areas for improvement include recognition of stroke mimics, consensus on treating less severe strokes, and use/interpretation of imaging.
引用
- Ramadan AR, Denny MC, Vahidy F, et al. Agreement Among Stroke Faculty and Fellows in Treating Ischemic Stroke Patients With Tissue-Type Plasminogen Activator and Thrombectomy. Stroke. 2016. PMID: 27879445. doi:10.1161/STROKEAHA.116.015214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。